Validity and feasibility of remote measurement systems for functional movement and posture assessments in people with axial spondylarthritis
Sign Up to like & getrecommendations! Published in 2022 at "Healthcare Technology Letters"
DOI: 10.1049/htl2.12038
Abstract: Abstract Introduction: This study aimed to estimate the criterion validity of functional movement and posture measurement using remote technology systems in people with and without Axial spondylarthritis (axSpA). Methods: Validity and agreement of the remote‐technology… read more here.
Keywords: movement posture; feasibility remote; functional movement; axial spondylarthritis ... See more keywords
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac174
Abstract: OBJECTIVES Many axial spondylarthritis (axSpA) patients receive a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) in combination with a tumour necrosis factor inhibitor (TNFi). However, the value of this co-therapy remains unclear. The objectives were to… read more here.
Keywords: retention; axial spondylarthritis; peripheral arthritis; remission ... See more keywords
Axial spondylarthritis following COVID-19 infection
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-252985
Abstract: Although SARS-CoV-2 syndrome primarily affects the lungs, systemic manifestations have been reported. New rheumatic immune-mediated inflammatory diseases have been reported following SARS-CoV-2 infection. We present a case of a woman in her mid-30s who developed… read more here.
Keywords: axial spondylarthritis; spondylarthritis following; infection; following covid ... See more keywords